I DIretrIz BrasIleIra De MIocarDItes e PerIcarDItes - Publicações ...

28
I Diretriz Brasileira de
Miocardites e Pericardites
Diretrizes
Referências
1. Carniel E, Sinagra G, Bussani R, Di Lenarda A, Pinamonti B, Lardieri G, et al. Fatal
myocarditis: morphologic and clinical features. Ital Heart J. 2004;5(9):702-6.
2. Kytö V, Saraste A, Voipio-Pulkki LM, Saukko P. Incidence of fatal myocarditis:
a population-based study in Finland. Am J Epidemiol. 2007;165(5):570-4.
3. Hahn EA, Hartz VL, Moon TE, O’Connell JB, Herskowitz A, McManus
BM, et al. The Myocarditis Treatment Trial: design, methods and patients
enrollment. Eur Heart J. 1995;16 (Suppl O):162-7.
4. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High
prevalence of viral genomes and multiple viral infections in the myocardium
of adults with “idiopathic” left ventricular dysfunction. Circulation.
2005;111(7):887-93.
5. Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood
and adolescence. JAMA. 1985;254(10):1321-5.
6. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, et
al. Noninvasive diagnosis of biopsy- proven cardiac amyloidosis. J Am Coll
Cardiol. 2004;43(3):410-5.
7. Frustaci A, Verardo R, Caldarulo M, Acconcia MC, Russo MA, Chimenti
C. Myocarditis in hypertrophic cardiomyopathy patients presenting acute
clinical deterioration. Eur Heart J. 2007;28(6):733-40.
8. JCS Joint Working Group. Guidelines for diagnosis and treatment of
myocarditis (JCS 2009): digest version. Circ J. 2011;75(3):734-43.
9. Montera MW, Pereira Y, Silva EL, Takiya C, Mesquita ET. Accuracy of non
invasive methods to diagnose Chronic Myocarditis in patients with dilated
cardiomyophaty. Eur J Heart Fail. 2011;. S10: S162–S165.
10. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274-88.
11. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S.
Lyme carditis: an important cause of reversible heart block. Ann Intern Med.
1989;110(5):339-45.
12. Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM,
Bacal F, et al; Sociedade Brasileira de Cardiologia. I Diretriz Latino
Americana para o diagnóstico e tratamento da cardiopatia chagásica.
Arq Bras Cardiol. 2011;97(2 supl. 3):1-47.
13. Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy
associated with clozapine. Lancet. 1999;354(9193):1841-5.
14. Stelts S, Taylor MH, Nappi J, Van Bakel AB. Mesalamine
associated hypersensitivity myocarditis in ulcerative colitis. Ann
Pharmacother. 2008;42(6):904-5.
15. Murphy JG, Wright RS, Bruce GK, Baddour LM, Farrell
MA, Edwards WD, et al. Eosinophilic-lymphocytic
myocarditis after smallpox vaccination. Lancet. 2003;362(9393):1378-80.
16. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis
MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll
Cardiol. 2004;43(9):1503-10.
17. Corssmit EP, Trip MD, Durrer JD. Loeffler’s endomyocarditis in the idiopathic
hypereosinophilic syndrome. Cardiology. 1999;91(4):272-6.
18. Nunes H, Freynet O, Naggara N, Soussan M, Weinman P, Diebold B, et al.
Cardiac sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):428-41.
19. Cooper LT Jr. Giant cell and granulomatous myocarditis. Heart Fail Clin.
2005;1(3):431-7.
20. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, et al.
Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart
J. 2000;140(5):785-91.
21. Midei MG, DeMent SH, Feldman AM, Hutchins
GM, Baughman KL. Peripartum myocarditis and
cardiomyopathy. Circulation. 1990;81(3):922-8.
22. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al.
Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779-92.
Arq Bras Cardiol: 2013; 100(4 Supl. 1): 1-36
23. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation
and cell death: learning from the past for the future. Circulation.
1999;99(8):1091-100.
24. Yuen S, Smith J, Caruso L, Balan M, Opavsky MA. The coxsackie-adenovirus
receptor induces an inflammatory cardiomyopathy independent of viral
infection. J Mol Cell Cardiol. 2011;50(5):826-40.
25. Oakley CM. Myocarditis, pericarditis and other pericardial diseases. Heart.
2000;84(4):449-54.
26. Ammann P, Naegeli B, Schuiki E, Straumann E, Frielingsdorf J, Rickli H, et al.
Long-term outcome of acute myocarditis is independent of cardiac enzyme
release. Int J Cardiol. 2003;89(2-3):217-22.
27. Mason JW. Myocarditis. Adv Intern Med. 1999;44:293-310.
28. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes
of human myocarditis. Arch Cardiovasc Dis. 2009;102(6-7):559-68.
29. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360(15):1526-38.
30. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity.
Mayo Clin Proc. 1985;60(7):463-8.
31. Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ, et al.
Myopericarditis following smallpox vaccination. Am J Epidemiol.
2004;160(7):642-51.
32. Spodick DH. Eosinophilic myocarditis. Mayo Clin Proc. 1997;72(10):996.
33. Narula N, McNamara DM. Endomyocardial biopsy and natural history of
myocarditis. Heart Fail Clin. 2005;1(3):391-406.
34. Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: most fatal of
autoimmune diseases. Semin Arthritis Rheum. 2000;30(1):1-16.
35. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet.
2003;361(9363):1111-8.
36. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of
sarcoidosis. Am Rev Respir Dis. 1987;135(3):747-60.
37. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, et al. A
prospective study of biopsy-proven myocarditis: prognostic relevance
of clinical and aetiopathogenetic features at diagnosis. Eur Heart J.
2007;28(11):1326-33.
38. Montera MW, Karinina A, Lycurgo G, Silva EE, Takya C, Evandro T, et al.
Clinical and functional profile of patients with viral miocarditis vs non viral
miocarditis. J Card Fail. 2006;12(6 Suppl):S28.
39. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and
treatment. Circulation. 2006;113(6):876-90.
40. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, et al. Active
myocarditis in the spectrum of acute dilated cardiomyopathies: clinical
features, histologic correlates, and clinical outcome. N Engl J Med.
1985;312(14):885-90.
41. Amabile NF, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute
fulminant myocarditis in children. Heart. 2006;92(9):1269-73.
42. Morimoto S, Kato S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, et al.
Role of myocardial interstitial edema in conduction disturbances in acute
myocarditis. Heart Vessels. 2006;21(6):356-60.
43. Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C, et al.
Comparison of clinical features and prognosis of cardiac sarcoidosis and
idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82(4):537-40.
44. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et
al. Virus serology in patients with suspected myocarditis: utility or futility?
Eur Heart J. 2011;32(7):897-903.
45. Morgera T, Di Lenarda A, Dreas L, Pinamonti B, Humar F, Bussani
R, et al. Electrocardiography of myocarditis revisited: clinical and
prognostic significance of electrocardiographic changes. Am Heart J.
1992;124(2):455-67.